A class action lawsuit has been filed against Insulet Corporation and certain officers for allegedly making false statements about the safety and manufacturing controls of its insulin delivery products during 2025-2026. The lawsuit claims Insulet failed to disclose manufacturing defects that posed safety risks, leading to two voluntary medical device corrections announced in March and May 2026. These disclosures caused significant stock price declines. Investors who bought Insulet securities during this period have until August 31, 2026, to join the lawsuit. This case highlights risks related to product safety and regulatory compliance in medical device companies.
The Canadian federal government has pledged $500 million to support the development of the Red Chris Block Cave project, a copper-gold mining operation by Imperial Metals and Newmont Corporation. This funding is part of the Canada-British Columbia Co...
Grabar Law Office is investigating claims against officers and directors of First Solar, Hub Group, Navan, and ZoomInfo for alleged breaches of fiduciary duties and securities fraud. The investigations focus on misleading statements and omissions rel...
Advanced Gold Exploration Inc. has issued 400,000 common shares as part of an option agreement to acquire the Muriel-Marr Project, a large land package of 403 mining claims in Ontario's Thunder Bay North district. This acquisition positions the compa...
The U.S. Treasury Department announced that Trump Accounts will officially launch on July 4, with all contributions initially invested in the low-cost State Street SPDR Portfolio S&P 500 ETF (SPYM). This ETF was chosen for its broad exposure to the U...
ProShares UltraPro S&P 500 (UPRO) offers triple daily leverage on the S&P 500, making it ideal for active traders who want to capitalize on short-term market swings. The analyst expects a flat to slightly positive outlook for the S&P 500 in 2026, lim...
